Showing results (151-160 of 232) with videos related to

Sort By:
Pageof 24
Stem Cells (Dayton, Ohio)|July 13, 2021
Human multipotent adult progenitor cells effectively reduce graft-vs-host disease while preserving graft-vs-leukemia activityLeland Metheny, Saada Eid, Patiwet Wuttisarnwattana, et al.
Pediatric Blood & Cancer|June 11, 2020
Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: The PEDECOR experienceDiana A Steppan, Ryan D Coleman, Heather K Viamonte, et al.
Blood Advances|September 18, 2025
Risk biomarkers of chronic GVHD in children aged 10 years or younger and children/adults older than 10 yearsAnna C Ferreira, Debjani Dutta, Courtney M Rowan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2012
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomesSung W Choi, Patrick Stiff, Kenneth Cooke, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 16, 2014
Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host diseaseGary D Glick, Rodrigue Rossignol, Costas A Lyssiotis, et al.
Blood|July 21, 2007
CCR1/CCL5 (RANTES) receptor-ligand interactions modulate allogeneic T-cell responses and graft-versus-host disease following stem-cell transplantationSung W Choi, Gerhard C Hildebrandt, Krystyna M Olkiewicz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Blood|October 17, 2021
Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learningShannon R McCurdy, Vedran Radojcic, Hua-Ling Tsai, et al.
Stem Cells (Dayton, Ohio)|October 23, 2014
Human mesenchymal stromal cells attenuate graft-versus-host disease and maintain graft-versus-leukemia activity following experimental allogeneic bone marrow transplantationJeffery J Auletta, Saada K Eid, Patiwet Wuttisarnwattana, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
The reparative immunologic consequences of stem cell transplantation as a cellular therapy for refractory Crohn's diseaseDaniela Guisado, Sayali Talware, Xiaoli Wang, et al.
Pageof 24